Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
01/2007
01/24/2007EP1472217B1 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
01/24/2007EP1180028B1 Il-8 receptor antagonists
01/24/2007EP0968206B8 N-heterocyclic derivatives as nos inhibitors
01/24/2007CN1902171A Benzylether amine compounds useful as CCR-5 antagonists
01/24/2007CN1901971A Cyclopropane compounds and pharmaceutical use thereof
01/24/2007CN1900079A New imidazole derivative, method for producing the same and use of the same
01/24/2007CN1296365C Imidazolinylmethyl aralkylsulfonamides
01/23/2007US7166724 Ionic liquids
01/23/2007US7166625 Method for treating fibrotic diseases and other indications
01/23/2007US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
01/23/2007US7166593 Glucocorticoid receptor modulators
01/23/2007US7166590 Antiischemic agents; cardiovascular disorders
01/23/2007CA2465149C Gas/vapor delivery from solid materials
01/18/2007WO2007009083A2 Compounds with activity at retinoic acid receptors
01/18/2007WO2007007018A1 Piperazine heteroaryl derivates as gpr38 agonists
01/18/2007WO2007006682A1 Phenylazo-acetoacetanilide derivatives with a polymer! zable functional group and related compounds as monomers for preparing polymeric pigment dispersants for inkjet inks
01/18/2007WO2007006389A1 Mixture of onium alkyl sulfonates and onium alkyl sulfites
01/18/2007WO2007006388A1 Method for the production of onium alkyl sulfites
01/18/2007WO2007006387A2 Onium-alkylsulfonate production method
01/18/2007US20070015918 Derivatives of 1,3-diones having a herbicidal activity
01/18/2007US20070015762 NPY Y5 antagonist
01/18/2007US20070015755 Novel compounds and compositions as protease inhibitors
01/18/2007US20070015730 [4-(tert-butyldimethylsilanyloxy)-3-oxobutyl]methylcarbamic acid tert-butyl ester; (R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-amine; for the treatment of cardiovascular disorders such as hypertension and chronic heart failure
01/18/2007US20070015220 Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins
01/18/2007DE102005032836A1 Verfahren zur Herstellung von Onium-Alkylsulfonaten A process for the preparation of onium alkylsulfonates
01/18/2007CA2613458A1 Compounds with activity at retinoic acid receptors
01/17/2007EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen
01/17/2007EP1742909A2 Anionic-sweetener-based ionic liquids and methods of use thereof
01/17/2007EP1742907A2 Certain chemical entities, compositions, and methods
01/17/2007CN1898187A Fluorinating agent and method for producing fluorine-containing compound using same
01/17/2007CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
01/16/2007US7164029 Process for the preparation of benzylimidazole derivatives
01/16/2007US7164028 Method for preparing β-alaninamides
01/16/2007US7164027 Aralkyl ester soft drugs
01/16/2007US7163955 useful in treating members of the Flaviviridae family of viruses
01/11/2007WO2007005174A2 4- (3 -hydroxy- and 3-aminomethyl-cyclohexen-3-ylmethyl) 1, 3-dihydroimdazole-2-thione derivatives as alpha-2 adrenergic agonists
01/11/2007WO2007005000A1 Method of synthesis of imidazole-amino acid derivatives and related compounds
01/11/2007WO2006089053A3 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
01/11/2007US20070010689 Optically active 3,3'-dithiobis(2-amino-2methylpropionic acid) derivative and process for producing optically active 2-amino-3-mercapto-2-methylpropionic acid derivative
01/11/2007US20070010669 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
01/11/2007US20070010563 Novel methods for the treatment of inflammatory diseases
01/11/2007US20070010536 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide
01/11/2007US20070010533 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
01/11/2007US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing
01/11/2007US20070007137 Ionic conducting gels, preparation method thereof and use of same
01/11/2007US20070007132 Transition metal complexes with bidentate ligand having an imidazole ring
01/10/2007EP1740565A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives
01/10/2007EP1740561A2 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them
01/10/2007EP1740550A1 Sulphur-linked imidazole compounds for the treament of hiv
01/10/2007EP1740549A2 Novel imidazoles
01/10/2007EP1740548A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
01/10/2007EP1740531A1 Indene derivatives and process for the preparation thereof
01/10/2007EP0988290B1 Carbonyldiimidazoles, their ester derivatives and method for their production
01/10/2007EP0821585B1 Use of alpha 1l-agonists in the treatment of urinary incontinence
01/10/2007CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
01/10/2007CN1894195A Ether compounds and compositions for cholesterol management and related uses
01/10/2007CN1894190A Method for the production of tetrahydrogeranylacetone
01/10/2007CN1891696A Dissymmetrical diazo compounds, compositions comprising them, method of coloring, and device
01/10/2007CN1891695A Symmetrical diazo compounds, compositions comprising them, method of coloring, and device
01/10/2007CN1891694A Method for preparing 1,3-dialkyl-2-imidazolidinone and 1,5- dialkyl-(1,3,5)triazahepane-2,4-diketone
01/10/2007CN1294132C Synthesis of temozolomide and analogs
01/10/2007CN1294122C Process for microwave synthesis of 1,3-disubstituted imidazole-2-thioketone
01/10/2007CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
01/09/2007US7160903 Sulfonylaminocarboxylic acids
01/09/2007CA2186844C Use of serotonin antagonists (5ht3) for treating fibromyalgia
01/04/2007WO2007002842A2 Substituted n-cinnamyl benzamides
01/04/2007WO2007002701A2 Anti-inflammatory aryl nitrile compounds
01/04/2007WO2007002563A1 Imidazole based lxr modulators
01/04/2007WO2007002559A1 Pyrazole based lxr modulators
01/04/2007WO2006047479A3 C-fms kinase inhibitors
01/04/2007WO2005123050A3 Five-membered heterocycles useful as serine protease inhibitors
01/04/2007US20070004790 Nonsedating Alpha-2 Agonists
01/04/2007US20070004788 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
01/04/2007US20070004758 [2-Alkyl-3-(phenylaminocarbonyl)-4-(4-pyrimidinyl, 5-pyrrolyl, or 4-pyridinyl)-5-(p-fluorophenyl)pyrrol-1-yl]dihydroxyalkanoic acids and 6-alkyl-gamma-hydroxyvalerolactones; antiinflammatory agents; carciovascular disorders; P38 map kinase inhibitors
01/04/2007CA2613522A1 Imidazole based lxr modulators
01/04/2007CA2613517A1 Pyrazole based lxr modulators
01/04/2007CA2613354A1 Non-nucleoside anti-hepacivirus agents and uses thereof
01/04/2007CA2612585A1 Anti-inflammatory aryl nitrile compounds
01/03/2007EP1738177A1 Method for analyzing n-terminal protein adducts
01/03/2007EP1737448A1 (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
01/03/2007EP1737447A1 (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
01/03/2007EP1737297A2 Imidazole compounds
01/03/2007EP1658273B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
01/03/2007CN1890238A Hydronopol derivatives as agonists on human ORL1 receptors
01/03/2007CN1890221A 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them
01/03/2007CN1887874A Ornidazole derivative and its prepn and use
01/03/2007CN1887828A Synthesis process of 18F lebeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
01/03/2007CN1292798C Ethylenedicysteine (EC)-drug conjugates
01/02/2007US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders
01/02/2007US7157483 Imidazole derivatives modulating the sodium channels
01/02/2007US7157476 Aminofurazan compounds useful as protein kinase inhibitors
01/02/2007US7157464 Substituted piperazines
01/02/2007US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2007US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
01/02/2007CA2465144C Injection system and method for releasing gas or vapor from a solid material
01/02/2007CA2465081C Sterilization system and method
01/02/2007CA2274464C Ketobenzamides as calpain inhibitors
01/02/2007CA2208129C Process for the preparation of chiral, nonracemic (4-aryl-2, 5-dioxoimidazo-lidin-1-yl)acetic acids
12/2006
12/28/2006WO2005087752A8 Substituted hydroxyethylamine aspartyl protease inhibitors
12/28/2006US20060293536 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile